Jenburkt Pharmaceuticals Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Jenburkt Pharmaceuticals Company Profile :

Jenburkt Pharmaceuticals Limited is an Indian company engaged in the business of manufacturing of pharmaceutical formulations.

The Company offers prescription and over-the-counter drugs for various therapeutic areas, including anthelmintic, anti-osteoporotic, anti-arthritic, antibiotics, aphrodisiac, dermatological, anti-diabetic, gastrointestinal, anti-hypertensive, hematinic, anti-inflammatory, analgesic, neuropathy, anti-malarial and protein preparation.

Company’s manufacturing plant is located at Sihor, Gujarat.


Jenburkt Pharmaceuticals ResultsBSE Code : 524731
NSE Symbol :
ISIN No. : INE354A01013
Industry : Pharmaceuticals
Face Value : Rs. 10.00


If you are an investor who has shares of Jenburkt Pharmaceuticals or you are an stock market analyst then i am sure you might for Quarterly Results of Jenburkt Pharmaceuticals.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Jenburkt Pharmaceuticals. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Jenburkt Pharmaceuticals.

Jenburkt Pharmaceuticals Q1 Results 2016-17 :

Jenburkt Pharmaceuticals will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income  –
Total Income  –
Expenditure  –
Interest  –
Depreciation  –
PBT  –
Tax
Net Profit
Equity
EPS

Jenburkt Pharmaceuticals will announce its Q2 FY 2016-17 Results in the month of October 2016.

Jenburkt Pharmaceuticals will announce its Q3 FY 2016-17 Results in the month of January 2017.

Jenburkt Pharmaceuticals will announce its Q4 FY 2016-17 Results in the month of April 2017.

Jenburkt Pharmaceuticals will announce its FY 2016-17 Results in the month of April 2017.

Note : We will update the results table above as and when results are announced. Visit again.

Jenburkt Pharmaceuticals Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue  93.59
Other Income  2.73  –
Total Income  96.32  –
Expenditure  -77.12  –
Interest  -0.38  –
Depreciation  -1.99  –
PBT  16.83  –
Tax  -6.05
Net Profit–  10.78  –
Equity  4.65  –
EPS  23.18  –

Note : If you like this information about Jenburkt Pharmaceuticals Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.